Colon Cancer

More Positive Results For Everist Genomics' OncoDefender-CRCEverist Genomics, a developer of personalized medicine, announced the publication of positive results from an international validation study which demonstrated that the OncoDefender-CRC colorectal cancer test result is a significant independent predictor of recurrence in node-negative, invasive colorectal cancer patients.
New Cancer Recurrence Test From Ann Arbor Firm
UM Cancer Center Gets $10.7M Fed GrantThe University of Michigan Comprehensive Cancer Center has received a five-year $10.7 million grant from the National Cancer Institute to study colorectal and pancreatic cancer.
UM Study Finds Surgery Complicaitons Lead To Chemo Delay